Patient Rating:

4.7 out of 5

39 Patient Ratings
26 Patient Comments

Stavros G. Drakos, M.D., Ph.D.

Patient Rating:

4.7 out of 5

39 Patient Ratings
26 Patient Comments

Clinical Details

Phone Number Clinical Office Address
(801) 585-3693
University Hospital
Heart Transplant Clinic
50 N Medical Dr
Salt Lake City, UT 84132
(801) 585-5122
University Hospital
Heart Failure Clinic
50 N Medical Dr
Salt Lake City, UT 84132


Dr. Drakos is an Associate Professor of Cardiology with Tenure, Co-Chief of the Heart Failure and Transplant Section/Division of Cardiology and Medical Director of the Mechanical Circulatory Support (MCS) Program, Univ. of Utah Healthcare. He is also the Director of Cardiovascular Research for the Division of Cardiology, Univ. of Utah.

Medical Training (MD, PhD, Residency, Fellowships) - See Info in the Academic Profile tab.

Post-training Clinical Faculty Appointments:

1). After completing Fellowships in (a) General Cardiology (U of Athens), (b) Heart Failure/Transplant/Cardiac Mechanical Support (U of Utah) and (c) Translational Research (U of Utah), Dr. Drakos joined the faculty at the U of Athens: (i) Clinically, he leveraged his advanced HF training in the US and played a pivotal role in starting the first chronic Mechanical Circulatory Support/VAD program in Greece, (ii) Academically, he focused his clinical research efforts on advancing the "Harefield-Athens Cardiac Recovery Program" in collaboration with Sir Magdi Yacoub's team, Harefield/Imperial College London.

2). Five years later he returned at the U of Utah and since 2008 he has been on the faculty at the Division of Cardiovascular Medicine.

Dr. Drakos is licensed to practice medicine both in the US and the European Union and is a member of several major US and European medical associations. He has published more than 100 peer-reviewed scientific manuscripts and book chapters and he and his mentees have received over the years several national and international competitive scientific Awards (NIH, AHA, ISHLT, HFSA, HCS, et al). For additional info regarding his academic background and job opportunities in his clinical reseach team or translational/lab-based team please visit the Academic Profile tab.

What kind of patients Dr. Drakos sees?

Dr. Drakos is a cardiology heart failure expert and receives referrals and consultations from a six- state region. His clinical specialties include General Cardiology, Heart Failure and Cardiomyopathies (including valvular heart disease), Heart Transplant, Cardiac Mechanical Support (VAD) and Cardiovascular Intensive Care Unit (CV-ICU).

Board Certification and Academic Information

Academic Departments Internal Medicine - Associate Professor
Academic Divisions Cardiovascular Medicine
Board Certification Board Certified in Cardiology (European Union and European Commission Board Certification)

Patient Ratings

The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

Likelihood of recommending care provider
My confidence in care provider
Time care provider spent with me
Care provider spoke using clear language
Care provider's effort to include me in decisions
Care provider's concern for questions & worries
Care provider's explanation of condition/problem
Wait time at clinic
Care provider's friendliness and courtesy

Patient Comments

Patient comments are gathered from our Press Ganey Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

June 20, 2016

Top shelf professional personnel

October 25, 2015

All excellent

August 06, 2015

I cried in reference to something that had nothing to do with my heart and the doctor gave me a hug and told me we would get through this together. That it would be okay and we would all work it out.

July 12, 2015

Very good

June 15, 2015

the care provider was so good help me with everthing

May 18, 2015

appreciate the care and kindness shown.

May 08, 2015

I would recommend U of U to anybody!!

April 19, 2015

Excellent experience in discussing alternatives in decisions that we made.

April 07, 2015

We needed medical help & we got it...THANK YOU VERY MUCH

April 07, 2015

I have nothing but the utmost respect for Dr. Draccos and complete confidence in him as a cardiologist. Extremely professional and a pleasure to see!

December 27, 2014

Excellent care

November 19, 2014

Doctor was a new one to me. Was not too sure about him.

November 14, 2014

My appointment was very through I had med changes with a follow-up call at home with orders phoned in to the lab for follow-up test My quality of life has improved 180%

July 07, 2014

Since we were in for a test, no results were available for the doctor or PA to share with us. They had seen us before, and were aware of the conditions, and of our concerns.

June 23, 2014

My previous appointment I was told that my heart may be getting worse and there was talk about ventricular assist or other items. It appears that my heart is the same as it was over the last few years based on the Echo. However, the problem of low BP and low Oxygen levels when active have not been addressed

February 18, 2014

Dr. Drakos was excellent, I was confident in his care and his attention to my concerns and issues. I agree with the comment that I read from another patient..... it would be beneficial to me to be able to listen to the discussion between the nurse and doctor. It would improve my understanding of my case and increase my peace of mind.

November 13, 2013

I really like Dr. Drakos. He is the only Dr. there who has been willing to think outside the box somewhat. He has been a big help when is comes to the breathing problems I was having. However, no one there has been willing or maybe able to address and figure out why my blood pressure drops so low so often since I had my defibrillator put in. No one seems curious enough to try to find out why. I bring it up at every visit but they don't know what to do about it so they simply tell me not to worry about it. This is frustrating for me! They don't have to live with the problem, I DO! and I'm tired of it. It is frustrating and debilitating in so many ways. If y'all can't figure it out please send me to someone who can, I would so appreciate it!

November 08, 2013

very good

October 22, 2013

all have treated me great

July 09, 2013

Dr. Drakos is really the only doctor in your office who has really taken an interest in the problems and symptoms I have. He's the only doctor who has taken the time to think outside the box and really try to find out what is going on with me. I have felt utterly dismissed by the other doctors in the Cardiology department. Because they couldn't find anything glaringly wrong with my heart they have basically ignored me. Dr. Drakos studied my chart and realized, because of my history, it could be something other than my heart causing my symptoms. Because of his expertise and inquisitiveness I think we might make some progress. At least he makes me feel that I am worth his time and effort and you can't possibly know how much that means to me. The other doctors in your office could take a few lessons from him. THINK OUTSIDE THE BOX!!!!!!

July 08, 2013

We have had an incredible experience with the facility and all staff!

July 01, 2013

from the reception to the doctor,all of them are exeptional!

June 24, 2013

The entire team that saw me was very interested in my symptoms and my case. This is something I have never experienced before. They did not tell me that, "it was all in my head" as many other physicians I have seen regarding these episodes have. They asked very thorough questions regarding my episodes, and wrote everything down. Over the past 6 years, I have never found a team of physicians that have helped me as much as they have.

April 29, 2013

I was treated like. person. with concern and care. I am asked if I understand my condition and explained what I don't. I am explained what is happening to me. I am reassured that I am in good hands. and I feel at ease because I am being talked to and looked at.

April 24, 2013

excellent service

October 29, 2012

This was the first time I met with the doctor, He did apologize for running so late, which was nice.

Academic Profile

Board Certification and Academic Information

Academic Departments Internal Medicine - Associate Professor
Academic Divisions Cardiovascular Medicine
Board Certification Board Certified in Cardiology (European Union and European Commission Board Certification)

Academic Office Locations

Academic Office Phone Number Academic Office Address
(801) 585-0700 George and Dolores Eccles Institute of Human Genetics
Molecular Medicine Program
15 N 2030 E
Salt Lake City, UT 84112
(801) 585-2340 School of Medicine
Division of Cardiovascular Medicine
30 N 1900 E
Salt Lake City, UT 84132

Academic Bio

Dr. Drakos is an Associate Professor of Cardiology with Tenure and Director of Cardiovascular Research for the Division of Cardiology, Univ. of Utah. He is the Co-Chief Heart Failure and Transplant Section and Medical Director of the Mechanical Circulatory Support (MCS) Program, Univ. of Utah Healthcare. His translational and clinical research interests are focused on cardiac recovery associated with unloading and MCS in both the chronic HF setting and the acute setting (i.e. acute HF/cardiogenic shock). He has published original work generated both in the clinical arena and in his laboratory (housed at the U of U Molecular Medicine program) which led to the establishment of the Utah Cardiac Recovery Program (UCAR). His ongoing research is focused on understanding the clinical, metabolic and molecular profile of the recovered human heart and utilize biological information and clinical characteristics derived from these studies to understand, predict and manipulate cardiac recovery applicable to all stages of HF. Dr. Drakos is co-chairing the NIH/NHLBI Working Group 'Advancing the Science of Myocardial Recovery with Mechanical Circulatory Support' (its executive summary and member list can be found at: Along the same lines Dr. Drakos is co-directing the Annual International Utah Cardiac Recovery Symposium (UCARS) - for more info please visit:


Dr. Drakos is a member of the AHA Research Leaders Academy and has received peer-reviewed extramural research support as Principal Investigator (PI) in both the US and Europe from the NIH (R01 Grants, CTSA Award), AHA (HF SFR Network-Clinical Project PI, CV Genome Phenome Grant), European Union/Marie Curie Grant/FP7 ('Unload Failing Heart'), Doris Duke Foundation (Translational Research), Department of Veterans Affairs, Intermountain Research Medical Foundation, Leventis Foundation (Pulsatile Vs. Continuous Flow Large Animal Research) and others.


From a historical perspective Dr. Drakos’s mentors (John Nanas, MD/PhD and Alexander Kralios, MD/PhD) also came to Utah from the U of Athens. Their mentors were Drs. Kolff ('father of artificial organs') Moulopoulos and Tsagaris and all the above excelled here in Utah in the 70's, 80's and 90's inspired by the concept of using "technology to replace biology". Working in the unique academic environment of the U of Utah they led important discoveries/patents and played a significant role in advancing the Mechanical Circulatory Support field through the pioneering of Intraaortic Balloon Pump Counterpulsation (IABP), Paraaortic Counterpulsation (PACD) and the Total Artificial Heart (TAH).

In a similarly inspiring academic environment Dr. Drakos is guiding his lab/translational science team and his clinical research team focused on using "technology to understand and manipulate biology" with the goal being myocardial recovery. For translational/lab research job opportunities (or clinical research opportunitites) please contact (please include your CV and potential referees). For Info regarding life in Utah please visit: and


1. M.D. (Summa Cum Laude) from the U of Athens (ranked as one of the leading medical schools worldwide: and the most competitive academic institution in Greece), and PhD from the same university with a PhD thesis entitled: 'Pulsatile vs. non-pulsatile cardiac mechanical support in a porcine model of heart failure', Award: 'Top 3 PhD Theses Univ. of Athens'.

2. Internal Medicine Residency and General Cardiology Fellowship, U of Athens (Mentor: John N. Nanas, MD/PhD).

3. Heart Failure/Transplant/MCS Fellowship, U of Utah (Mentor: Dale G. Renlund, MD).

4. Athens-Harefield Recovery Program Clinical Fellowship, (Mentor: Sir Magdi H. Yacoub, MD)

5. Translational Research Fellowship, Molecular Medicine Program/Eccles Institute of Human Genetics, U of Utah (Mentor: Dean Y. Li, MD/PhD).

Research Statement

See brief paragraph above (below Academic Bio)


Education History

Type School Degree
Fellowship University of Utah/ Eccles Institute of Human Genetics
Molecular Medicine Research Program, Translational Research Fellowship
Fellowship University of Athens
General Cardiology Fellowship
Fellowship University of Utah & U.T.A.H. Cardiac Transplant Program
Heart Failure/ Transplant/ Mechanical Support Fellowship
Doctoral Training University of Athens
Pulsatile vs. Non Pulsatile Mechanical Support in a Porcine Model of Heart Failure, Summa Cum Laude
Residency University of Athens
Internal Medicine
Professional Medical University of Athens
Medicine, Summa Cum Laude


Selected Provider Publications

Journal Article

  1. Drakos SG, Mehra MR (2016). Clinical myocardial recovery during long-term mechanical support in advanced heart failure: insights into moving the field forward. J Heart Lung Transplant, 35(4), 413-20.
  2. Wever-Pinzon O, Drakos SG, McKellar SH, Kfoury AG, Horne BD, Li DY, Caine W, Stehlik J, Fang JC, Selzman CH (2016). The Impact of Therapeutic Strategy on Left Ventricular Assist Device Explantation for Cardiac Recovery: Insights From the Interagency Registry for Mechanically Assisted Circulatory Support. J Am Coll Cardiol.
  3. Diakos NA, Navankasattusas S, Abel ED, Rutter J, McCreath L, Ferrin P, McKellar SH, Richardson R, Deberardinis R, Kfoury AG, Selzman CH, Stehlik J, Fang JC, Li DY, Drakos SG (2016). Evidence of glycolysis upregulation and pyruvate mitochondrial oxidation mismatch during mechanical unloading of the failing human heart: implications for cardiac reloading and conditioning. JACC Basic Transl Sci.
  4. Al-Sarie M, Rauf A, Kfoury A, Catino A, Wever-Pinzon J, Bonios M, Alharethi R, Reid BB, Wever-Pinzon O, McKellar SH, Li DY, Fang JC, Stehlik J, Selzman CH, Drakos SG (2016). Myocardial Structural and Functional Response after Long-Term Mechanical Unloading With Continuous-Flow Left Ventricular Assist Device: Axial- versus Centrifugal-Flow. JACC Heart Fail.
  5. Healy AH, Stehlik J, Edwards LB, McKellar SH, Drakos SG, Selzman CH (2016). Predictors of 30-day post-transplant mortality in patients bridged to transplantation with continuous-flow left ventricular assist devices--An analysis of the International Society for Heart and Lung Transplantation Transplant Registry. J Heart Lung Transplant, 35(1), 34-9.
  6. Shah RU, Stehlik J, Drakos SG, Fang JC (2015). Administrative data: proceed with caution. J Am Coll Cardiol, 65(10), 1063.
  7. Healy AH, Koliopoulou A, Drakos SG, McKellar SH, Stehlik J, Selzman CH (2015). Patient-controlled conditioning for left ventricular assist device-induced myocardial recovery. Ann Thorac Surg, 99(5), 1794-6.
  8. Hong K, Jeong EK, Wall TS, Drakos SG, Kim D (2015). Wideband arrhythmia-Insensitive-rapid (AIR) pulse sequence for cardiac T1 mapping without image artifacts induced by an implantable-cardioverter-defibrillator. Magn Reson Med, 74(2), 336-45.
  9. Diakos NA, Selzman CH, Stehlik J, Sachse FB, Kfoury AG, Koliopoulou A, McKellar S, Fang JC, Li DY, Drakos SG (2015). Reply: does size matter? In search of a physiological definition of myocardial atrophy. J Am Coll Cardiol, 65(19), 2156-7.
  10. Wachter SB, McCandless SP, Gilbert EM, Stoddard GJ, Kfoury AG, Reid BB, McKellar SH, Nativi-Nicolau J, Saidi A, Barney J, McCreath L, Koliopoulou A, Wright SE, Fang JC, Stehlik J, Selzman CH, Drakos SG (2015). Elevated resting heart rate in heart transplant recipients: innocent bystander or adverse prognostic indicator? Clin Transplant, 29(9), 829-34.
  11. Witman MA, Garten RS, Gifford JR, Groot HJ, Trinity JD, Stehlik J, Nativi JN, Selzman CH, Drakos SG, Richardson RS (2015). Further Peripheral Vascular Dysfunction in Heart Failure Patients With a Continuous-Flow Left Ventricular Assist Device: The Role of Pulsatility. JACC Heart Fail, 3(9), 703-11.
  12. Diakos NA, Selzman CH, Sachse FB, Stehlik J, Kfoury AG, Wever-Pinzon O, Catino A, Alharethi R, Reid BB, Miller DV, Salama M, Zaitsev AV, Shibayama J, Li H, Fang JC, Li DY, Drakos SG (2014). Myocardial atrophy and chronic mechanical unloading of the failing human heart: implications for cardiac assist device-induced myocardial recovery. J Am Coll Cardiol, 64(15), 1602-12.
  13. Park SY, Gifford JR, Andtbacka RH, Trinity JD, Hyngstrom JR, Garten RS, Diakos NA, Ives SJ, Dela F, Larsen S, Drakos S, Richardson RS (2014). Cardiac, skeletal, and smooth muscle mitochondrial respiration: are all mitochondria created equal? Am J Physiol Heart Circ Physiol, 307(3), H346-52.
  14. Wever-Pinzon O, Romero J, Kelesidis I, Wever-Pinzon J, Manrique C, Budge D, Drakos SG, Pina IL, Kfoury AG, Garcia MJ, Stehlik J (2014). Coronary computed tomography angiography for the detection of cardiac allograft vasculopathy: a meta-analysis of prospective trials. J Am Coll Cardiol, 63(19), 1992-2004.
  15. Madden JL, Drakos SG, Stehlik J, McKellar SH, Rondina MT, Weyrich AS, Selzman CH (2014). Baseline red blood cell osmotic fragility does not predict the degree of post-LVAD hemolysis. ASAIO J, 60(5), 524-8.
  16. Abdullah OM, Drakos SG, Diakos NA, Wever-Pinzon O, Kfoury AG, Stehlik J, Selzman CH, Reid BB, Brunisholz K, Verma DR, Myrick C, Sachse FB, Li DY, Hsu EW (2014). Characterization of diffuse fibrosis in the failing human heart via diffusion tensor imaging and quantitative histological validation. NMR Biomed, 27(11), 1378-86.
  17. Diakos NA, Selzman CH, Sachse FB, Stehlik J, Kfoury AG, Wever-Pinzon O, Catino A, Alharethi R, Reid BB, Miller DV, Salama ME, Zaitsev AV, Shibayama J, Li H, Fang JC, Li DY, Drakos SG (In press). Myocardial atrophy and metabolic changes during mechanical unloading of the failing human heart: implications for ventricular assist devices-induced cardiac recovery. J Am Coll Cardiol.
  18. Drakos SG (2014). The Odyssey of Chronic Cardiac Mechanical Support. J Am Coll Cardiol, Feb 27.
  19. Frech T, De Domenico I, Murtaugh MA, Revelo MP, Li DY, Sawitzke AD, Drakos SG (2014). Autophagy is a key feature in the pathogenesis of scytemic sclerosis. Rheumatol Int, 34(3), 435-439.
  20. Omar Wever-Pinzon, Jorge Romero, Iosif Kelesidis, James Wever-Pinzon, Carlos Manrique, Deborah Budge, Drakos SG, Ileana Pina, Abdallah G Kfoury, Mario J Garcia, Josef Stehlik (3/2014). Coronary Computed Tomography Angiography for the Detection of Cardiac Allograft Vasculopathy: A Meta-Analysis of Prospective Trials ONLINE FIRST. J Am Coll Cardiol.
  21. Wozniak CJ, Stehlik J, Baird BC, McKellar SH, Song HK, Drakos SG, Selzman CH (2014). Ventricular assist devices or inotropic agents in status 1A patients? Survival analysis of the United Network of Organ Sharing database. Ann Thorac Surg, 97(4), 1364-71; discussion 1371-2.
  22. Wever-Pinzon O, Kfoury AG, Selzman CH, Li DY, Drakos SG (2013). Left ventricular assist devices in chronic heart failure: more questions than answers? J Am Coll Cardiol, 62(23), 2257-8.
  23. Healy AH, Baird BC, Drakos SG, Stehlik J, Selzman CH (2013). Impact of ventricular assist device complications on posttransplant survival: an analysis of the United network of organ sharing database. Ann Thorac Surg, 95(3), 870-5.
  24. Wever-Pinzon O, Drakos SG, Kfoury AG, Nativi JN, Gilbert EM, Everitt M, Alharethi R, Brunisholz K, Bader FM, Li DY, Selzman CH, Stehlik J (2013). Morbidity and mortality in heart transplant candidates supported with mechanical circulatory support: is reappraisal of the current United network for organ sharing thoracic organ allocation policy justified? Circulation, 127(4), 452-62.
  25. Wever-Pinzon O, Selzman CH, Drakos SG, Saidi A, Stoddard GJ, Gilbert EM, Labedi M, Reid BB, Davis ES, Kfoury AG, Li DY, Stehlik J, Bader F (2013). Pulsatility and the risk of nonsurgical bleeding in patients supported with the continuous-flow left ventricular assist device HeartMate II. Circ Heart Fail, 6(3), 517-26.
  26. Drakos SG, Wever-Pinzon O, Selzman CH, Gilbert EM, Alharethi R, Reid BB, Saidi A, Diakos NA, Stoker S, Davis ES, Movsesian M, Li DY, Stehlik J, Kfoury AG (2013). Magnitude and time course of changes induced by continuous-flow left ventricular assist device unloading in chronic heart failure: insights into cardiac recovery. J Am Coll Cardiol, 61(19), 1985-94.
  27. Drakos SG, Kfoury AG, Stehlik J, Selzman CH, Reid BB, Terrovitis JV, Nanas JN, Li DY (2012). Bridge to recovery: understanding the disconnect between clinical and biological outcomes. Circulation, 126(2), 230-41.
  28. Bonios MJ, Terrovitis JV, Drakos SG, Katsaros F, Pantsios C, Nanas SN, Kanakakis J, Alexopoulos G, Toumanidis S, Anastasiou-Nana M, Nanas JN (2012). Comparison of three different regimens of intermittent inotrope infusions for end stage heart failure. Int J Cardiol, 159(3), 225-9.
  29. Kfoury AG, Snow GL, Budge D, Alharethi RA, Stehlik J, Everitt MD, Miller DV, Drakos SG, Reid BB, Revelo MP, Gilbert EM, Selzman CH, Bader FM, Connelly JJ, Hammond ME (2012). A longitudinal study of the course of asymptomatic antibody-mediated rejection in heart transplantation. J Heart Lung Transplant, 31(1), 46-51.
  30. Wozniak CJ, Baird BC, Stehlik J, Drakos SG, Bull DA, Patel AN, Selzman CH (2012). Improved survival in heart transplant patients living at high altitude. J Thorac Cardiovasc Surg, 143(3), 735-741.e1.
  31. Revelo MP, Miller DV, Stehlik J, Brunisholz K, Drakos S, Gilbert EM, Everitt M, Budge D, Alharethi R, Snow G, Hammond EH, Kfoury AG (2012). Longitudinal evaluation of microvessel density in survivors vs. nonsurvivors of cardiac pathologic antibody-mediated rejection. Cardiovasc Pathol, 21(6), 445-54.
  32. Frech TM, Revelo MP, Drakos SG, Murtaugh MA, Markewitz BA, Sawitzke AD, Li DY (2012). Vascular leak is a central feature in the pathogenesis of systemic sclerosis. J Rheumatol, 39(7), 1385-91.
  33. Stavrakis S, Terrovitis J, Tsolakis E, Drakos S, Dalianis A, Bonios M, Koudoumas D, Malliaras K, Nanas J (2011). Relationship between retrograde coronary blood flow and the extent of no-reflow and infarct size in a porcine ischemia-reperfusion model. J Cardiovasc Transl Res, 4(1), 99-105.
  34. Drakos SG, Terrovitis JV, Nanas JN, Charitos EI, Ntalianis AS, Malliaras KG, Diakos N, Koudoumas D, Theodoropoulos S, Yacoub MH, Anastasiou-Nana MI (2011). Reverse electrophysiologic remodeling after cardiac mechanical unloading for end-stage nonischemic cardiomyopathy. Ann Thorac Surg, 91(3), 764-9.
  35. Chan AC, Drakos SG, Ruiz OE, Smith AC, Gibson CC, Ling J, Passi SF, Stratman AN, Sacharidou A, Revelo MP, Grossmann AH, Diakos NA, Davis GE, Metzstein MM, Whitehead KJ, Li DY (2011). Mutations in 2 distinct genetic pathways result in cerebral cavernous malformations in mice. J Clin Invest, 121(5), 1871-81.
  36. Nativi JN, Drakos SG, Kucheryavaya AY, Edwards LB, Selzman CH, Taylor DO, Hertz MI, Kfoury AG, Stehlik J (2011). Changing outcomes in patients bridged to heart transplantation with continuous- versus pulsatile-flow ventricular assist devices: an analysis of the registry of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant, 30(8), 854-61.
  37. Pierrakos CN, Bonios MJ, Drakos SG, Charitos EI, Tsolakis EJ, Ntalianis A, Nanas SN, Charitos CE, Nanas JN, Terrovitis JV (2011). Mechanical assistance by intra-aortic balloon pump counterpulsation during reperfusion increases coronary blood flow and mitigates the no-reflow phenomenon: an experimental study. Artif Organs, 35(9), 867-74.
  38. Wever Pinzon O, Stoddard G, Drakos SG, Gilbert EM, Nativi JN, Budge D, Bader F, Alharethi R, Reid B, Selzman CH, Everitt MD, Kfoury AG, Stehlik J (2011). Impact of donor left ventricular hypertrophy on survival after heart transplant. Am J Transplant, 11(12), 2755-61.
  39. Healy AH, Mason NO, Hammond ME, Reid BB, Clayson SE, Drakos SG, Kfoury AG, Patel AN, Bull DA, Budge D, Alharethi RA, Bader FM, Gilbert EM, Stehlik J, Selzman CH (2011). Allograft rejection in patients supported with continuous-flow left ventricular assist devices. Ann Thorac Surg, 92(5), 1601-7; discussion 1607.
  40. Dimopoulos S, Diakos N, Tseliou E, Tasoulis A, Mpouchla A, Manetos C, Katsaros L, Drakos S, Terrovitis J, Nanas S (2011). Chronotropic incompetence and abnormal heart rate recovery early after left ventricular assist device implantation. Pacing Clin Electrophysiol, 34(12), 1607-14.
  41. Bull DA, Reid BB, Selzman CH, Mesley R, Drakos S, Clayson S, Stoddard G, Gilbert E, Stehlik J, Bader F, Kfoury A, Budge D, Eckels DD, Fuller A, Renlund D, Patel AN (2010). The impact of bridge-to-transplant ventricular assist device support on survival after cardiac transplantation. J Thorac Cardiovasc Surg, 140(1), 169-73.
  42. Tasoulis A, Papazachou O, Dimopoulos S, Gerovasili V, Karatzanos E, Kyprianou T, Drakos S, Anastasiou-Nana M, Roussos C, Nanas S (2010). Effects of interval exercise training on respiratory drive in patients with chronic heart failure. Respir Med, 104(10), 1557-65.
  43. Brush S, Budge D, Alharethi R, McCormick AJ, MacPherson JE, Reid BB, Ledford ID, Smith HK, Stoker S, Clayson SE, Doty JR, Caine WT, Drakos S, Kfoury AG (2010). End-of-life decision making and implementation in recipients of a destination left ventricular assist device. J Heart Lung Transplant, 29(12), 1337-41.
  44. Drakos SG, Athanasoulis T, Malliaras KG, Terrovitis JV, Diakos N, Koudoumas D, Ntalianis AS, Theodoropoulos SP, Yacoub MH, Nanas JN (2010). Myocardial sympathetic innervation and long-term left ventricular mechanical unloading. JACC Cardiovasc Imaging, 3(1), 64-70.
  45. Drakos SG, Janicki L, Horne BD, Kfoury AG, Reid BB, Clayson S, Horton K, Haddad F, Li DY, Renlund DG, Fisher PW (2010). Risk factors predictive of right ventricular failure after left ventricular assist device implantation. Am J Cardiol, 105(7), 1030-5.
  46. Dimopoulos SK, Drakos SG, Terrovitis JV, Tzanis GS, Nanas SN (2010). Improvement in respiratory muscle dysfunction with continuous-flow left ventricular assist devices. J Heart Lung Transplant, 29(8), 906-8.
  47. Singhal AK, Drakos SG, Kfoury AG, Horne BD, Verma DR, Stehlik J (2010). Prolonged allograft ischemic time is not associated with higher incidence of antibody-mediated rejection. J Heart Lung Transplant, 29(10), 1198-200.
  48. Drakos SG, Kfoury AG, Hammond EH, Reid BB, Revelo MP, Rasmusson BY, Whitehead KJ, Salama ME, Selzman CH, Stehlik J, Clayson SE, Bristow MR, Renlund DG, Li DY (2010). Impact of mechanical unloading on microvasculature and associated central remodeling features of the failing human heart. J Am Coll Cardiol, 56(5), 382-91.
  49. Verma DR, Drakos SG, Stehlik J, Horne BD, Kfoury AG (2010). Effect of preservation solution choice on antibody-mediated rejection after heart transplantation. J Heart Lung Transplant, 29(11), 1314-5.
  50. Kotter JR, Drakos SG, Horne BD, Hammond EH, Stehlik J, Bull DA, Reid BB, Gilbert EM, Everitt M, Alharethi R, Budge D, Verma DR, Li DY, Kfoury AG (2010). Effect of blood product transfusion-induced tolerance on incidence of cardiac allograft rejection. Transplant Proc, 42(7), 2687-92.
  51. Bonios MJ, Pierrakos CN, Argiriou M, Dalianis A, Terrovitis JV, Dolou P, Drakos SG, Koudoumas D, Charitos CE, Anastasiou-Nana MI (2010). Increase in coronary blood flow by intra-aortic balloon counterpulsation in a porcine model of myocardial reperfusion. Int J Cardiol, 138(3), 253-60.
  52. Gerovasili V, Drakos S, Kravari M, Malliaras K, Karatzanos E, Dimopoulos S, Tasoulis A, Anastasiou-Nana M, Roussos C, Nanas S (2009). Physical exercise improves the peripheral microcirculation of patients with chronic heart failure. J Cardiopulm Rehabil Prev, 29(6), 385-91.
  53. Singhal AK, Sheng X, Drakos SG, Stehlik J (2009). Impact of donor cause of death on transplant outcomes: UNOS registry analysis. Transplant Proc, 41(9), 3539-44.
  54. Kfoury AG, Hammond ME, Snow GL, Drakos SG, Stehlik J, Fisher PW, Reid BB, Everitt MD, Bader FM, Renlund DG (2009). Cardiovascular mortality among heart transplant recipients with asymptomatic antibody-mediated or stable mixed cellular and antibody-mediated rejection. J Heart Lung Transplant, 28(8), 781-4.
  55. Drakos SG, Kfoury AG, Kotter JR, Reid BB, Clayson SE, Selzman CH, Stehlik J, Fisher PW, Merida M 3rd, Eckels DD, Brunisholz K, Horne BD, Stoker S, Li DY, Renlund DG (2009). Prior human leukocyte antigen-allosensitization and left ventricular assist device type affect degree of post-implantation human leukocyte antigen-allosensitization. J Heart Lung Transplant, 28(8), 838-42.
  56. Whitehead KJ, Chan AC, Navankasattusas S, Koh W, London NR, Ling J, Mayo AH, Drakos SG, Jones CA, Zhu W, Marchuk DA, Davis GE, Li DY (2009). The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases. Nat Med, 15(2), 177-84.
  57. Drakos SG, Kanakakis JV, Nanas S, Bonios M, Kaldara E, Katsaros F, Pantsios C, Nanas JN (2009). Intermittent inotropic infusions combined with prophylactic oral amiodarone for patients with decompensated end-stage heart failure. J Cardiovasc Pharmacol, 53(2), 157-61.
  58. Tsagalou EP, Kanakakis J, Anastasiou-Nana MI, Drakos SG, Ntalianis AS, Malliaras K, Lazaris N, Katsaros F, Nanas JN (2009). Hemodynamic effects of levosimendan in acute myocardial infarction complicated by cardiogenic shock and high systemic vascular resistance. Acute Card Care, 11(2), 99-106.
  59. Kanakakis J, Nanas JN, Tsagalou EP, Maroulidis GD, Drakos SG, Ntalianis AS, Tzoumele P, Skoumbourdis E, Charbis P, Rokas S, Anastasiou-Nana M (2009). Multicenter randomized trial of facilitated percutaneous coronary intervention with low-dose tenecteplase in patients with acute myocardial infarction: the Athens PCI trial. Catheter Cardiovasc Interv, 74(3), 398-405.
  60. Drakos SG, Bonios MJ, Anastasiou-Nana MI, Tsagalou EP, Terrovitis JV, Kaldara E, Maroulidis G, Nanas SN, Kanakakis J, Nanas JN (2009). Long-term survival and outcomes after hospitalization for acute myocardial infarction complicated by cardiogenic shock. Clin Cardiol, 32(8), E4-8.
  61. Kravari M, Vasileiadis I, Gerovasili V, Karatzanos E, Tasoulis A, Kalligras K, Drakos SG, Dimopoulos S, Anastasiou-Nana M, Nanas S (2008). Effects of a 3-month rehabilitation program on muscle oxygenation in congestive heart failure patients as assessed by NIRS. Int J Ind Ergon.
  62. Struber M, Sander K, Lahpor J, Ahn H, Litzler PY, Drakos SG, Musumeci F, Schlensak C, Friedrich I, Gustafsson R, Oertel F, Leprince P (2008). HeartMate II left ventricular assist device; early European experience. Eur J Cardiothorac Surg, 34(2), 289-94.
  63. Drakos SG, Anastasiou-Nana MI, Terrovitis JV, Tsagalou EP, Kanakakis J, Ntalianis A, Lazaris N, Maroulidis G, Venetsanakos J, Bonios M, Nanas JN (2008). Intra-aortic balloon counterpulsation and delayed revascularization for myocardial infarction and shock in the absence of primary angioplasty: a treatment strategy with or without thrombolysis? Coron Artery Dis, 19(7), 521-6.
  64. Tsagalou EP, Anastasiou-Nana M, Agapitos E, Gika A, Drakos SG, Terrovitis JV, Ntalianis A, Nanas JN (2008). Depressed coronary flow reserve is associated with decreased myocardial capillary density in patients with heart failure due to idiopathic dilated cardiomyopathy. J Am Coll Cardiol, 52(17), 1391-8.
  65. Ntalianis AS, Drakos SG, Charitos C, Dolou P, Pierrakos CN, Terrovitis JV, Papaioannou T, Charitos E, Nanas JN (2008). Effects of intra-aortic balloon pump versus centrifugal pump on myocardial energetics and systemic circulation in a porcine model of rapidly worsening acute heart failure. ASAIO J, 54(6), 600-5.
  66. Papazachou O, Anastasiou-Nana M, Sakellariou D, Tassiou A, Dimopoulos S, Venetsanakos J, Maroulidis G, Drakos S, Roussos C, Nanas S (2007). Pulmonary function at peak exercise in patients with chronic heart failure. Int J Cardiol, 118(1), 28-35.
  67. Drakos SG, Kfoury AG, Gilbert EM, Long JW, Stringham JC, Hammond EH, Jones KW, Bull DA, Hagan ME, Folsom JW, Horne BD, Renlund DG (2007). Multivariate predictors of heart transplantation outcomes in the era of chronic mechanical circulatory support. Ann Thorac Surg, 83(1), 62-7.
  68. Drakos SG, Kfoury AG, Gilbert EM, Horne BD, Long JW, Stringham JC, Campbell BA, Renlund DG (2007). Effect of reversible pulmonary hypertension on outcomes after heart transplantation. J Heart Lung Transplant, 26(4), 319-23.
  69. Drakos SG, Stringham JC, Long JW, Gilbert EM, Fuller TC, Campbell BK, Horne BD, Hagan ME, Nelson KE, Lindblom JM, Meldrum PA, Carlson JF, Moore SA, Kfoury AG, Renlund DG (2007). Prevalence and risks of allosensitization in HeartMate left ventricular assist device recipients: the impact of leukofiltered cellular blood product transfusions. J Thorac Cardiovasc Surg, 133(6), 1612-9.
  70. Drakos SG, Kfoury AG, Long JW, Stringham JC, Gilbert EM, Horne BD, Hagan MB, Nelson K, Renlund DG (2007). Similar transplantation outcomes in patients bridged with cardiac assist devices for acute cardiogenic shock versus chronic heart failure. Eur J Heart Fail, 9(8), 845-9.
  71. Dimopoulos S, Anastasiou-Nana M, Sakellariou D, Drakos SG, Kapsimalakou S, Maroulidis G, Roditis P, Roussos C, Nanas S (2006). Effects of exercise rehabilitation program on heart rate recovery in patients with chronic heart failure. Eur J Cardiovasc Prev Rehabil, 13(1), 67-73.
  72. Nanas SN, Nanas JN, Sakellariou DCh, Dimopoulos SK, Drakos SG, Kapsimalakou SG, Mpatziou CA, Papazachou OG, Dalianis AS, Anastasiou-Nana MI, Roussos C (2006). VE/VCO2 slope is associated with abnormal resting haemodynamics and is a predictor of long-term survival in chronic heart failure. Eur J Heart Fail, 8(4), 420-7.
  73. Drakos SG, Kfoury AG, Long JW, Stringham JC, Gilbert EM, Moore SA, Campbell BK, Nelson KE, Horne BD, Renlund DG (2006). Effect of mechanical circulatory support on outcomes after heart transplantation. J Heart Lung Transplant, 25(1), 22-8.
  74. Terrovitis JV, Anastasiou-Nana MI, Alexopoulos GP, Tsolakis EJ, Margari ZJ, Drakos SG, Tsagalou EP, Papazoglou P, Efentakis S, Nanas JN (2006). Prevalence and prognostic significance of anemia in patients with congestive heart failure treated with standard vs high doses of enalapril. J Heart Lung Transplant, 25(3), 333-8.
  75. Drakos SG, Kfoury AG, Long JW, Stringham JC, Fuller TC, Nelson KE, Campbell BK, Gilbert EM, Renlund DG (2006). Low-dose prophylactic intravenous immunoglobulin does not prevent HLA sensitization in left ventricular assist device recipients. Ann Thorac Surg, 82(3), 889-93.
  76. Nanas JN, Matsouka C, Karageorgopoulos D, Leonti A, Tsolakis E, Drakos SG, Tsagalou EP, Maroulidis GD, Alexopoulos GP, Kanakakis JE, Anastasiou-Nana MI (2006). Etiology of anemia in patients with advanced heart failure. J Am Coll Cardiol, 48(12), 2485-9.
  77. Anastasiou-Nana MI, Tsagalou EP, Charitos C, Siafakas KX, Drakos S, Terrovitis JV, Ntalianis A, Doufas A, Mavrikakis J, Nanas JN (2005). Effects of transient myocardial ischemia on the ventricular defibrillation threshold. Pacing Clin Electrophysiol, 28(2), 97-101.
  78. Anastasiou-Nana MI, Tsagalou EP, Mavrikakis EM, Siafakas KX, Tsolakis EJ, Drakos SG, Dalianis A, Karelas J, Terrovitis JV, Nanas JN (2005). Myocardial ischaemic preconditioning in the pig has no effect on the ventricular fibrillation and defibrillation thresholds. Resuscitation, 64(3), 373-6.
  79. Drakos SG, Charitos CE, Ntalianis A, Terrovitis JV, Siafakas KX, Dolou P, Pierrakos C, Charitos E, Karelas J, Nanas JN (2005). Comparison of pulsatile with nonpulsatile mechanical support in a porcine model of profound cardiogenic shock. ASAIO J, 51(1), 26-9.
  80. Nanas JN, Tsolakis E, Terrovitis JV, Eleftheriou A, Drakos SG, Dalianis A, Charitos CE (2004). Moderate systemic hypotension during reperfusion reduces the coronary blood flow and increases the size of myocardial infarction in pigs. Chest, 125(4), 1492-9.
  81. Tsagalou EP, Anastasiou-Nana MI, Charitos CE, Siafakas CX, Drakos SG, Ntalianis A, Terrovitis JV, Mavrikakis EM, Doufas A, Nanas JN (2004). Time course of fibrillation and defibrillation thresholds after an intravenous bolus of amiodarone--an experimental study. Resuscitation, 61(1), 83-9.
  82. Drakos SG, Papamichael CM, Alexopoulos GP, Anastasiou-Nana MI, Stathopoulos JV, Nanas JN (2003). Effects of high doses versus standard doses of enalapril on endothelial cell function in patients with chronic congestive heart failure secondary to idiopathic dilated or ischemic cardiomyopathy. Am J Cardiol, 91(7), 885-8.
  83. Drakos SG, AnastasiouNana M, Nanas J (2001). Exacerbation of variant angina by metoprolol resulting in syncope due to transient atrioventricular block. Int J Cardiol, 82, 83-85.
  84. Nanas S, Nanas J, Kassiotis C, Nikolaou C, Tsagalou E, Sakellariou D, Terovitis I, Papazachou O, Drakos S, Papamichalopoulos A, Roussos C (2001). Early recovery of oxygen kinetics after submaximal exercise test predicts functional capacity in patients with chronic heart failure. Eur J Heart Fail, 3(6), 685-92.
  85. Ziras N, Rozakou A, Skoura S, Drakos S, Venetsanou V, Tsiggalakis D, Fragaki 924, Giannakakis T, Athanassiou A (2001). Soluble transferrin receptor: An early predicting index of response to epoetin alfa treatment for the prophylaxis of chemotherapy-induced anemia in patients with solid tumors. J BUON, 6, 67-73.


  1. Ferrin PC, McCreath L, Navankasattusas S, Drakos SG (In Press). Recovery versus Remission: Clinical and Molecular Insights. [Review]. Heart Failure Clinics.
  2. Selzman CH, Madden JL, Healy AH, McKellar SH, Koliopoulou A, Stehlik J, Drakos SG (2015). Bridge to removal: a paradigm shift for left ventricular assist device therapy. [Review]. Ann Thorac Surg, 99(1), 360-7.
  3. Wever-Pinzon O, Drakos SG, Fang JC (2015). Team-based Care for Advanced Heart Failure. [Review]. Heart Fail Clin, 11(3), 467-77.
  4. Wever-Pinzon O, Stehlik J, Kfoury AG, Terrovitis JV, Diakos NA, Charitos C, Li DY, Drakos SG (2012). Ventricular assist devices: pharmacological aspects of a mechanical therapy. [Review]. Pharmacol Ther, 134(2), 189-99.
  5. Drakos SG, Kfoury AG, Selzman CH, Verma DR, Nanas JN, Li DY, Stehlik J (2011). Left ventricular assist device unloading effects on myocardial structure and function: current status of the field and call for action. [Review]. Curr Opin Cardiol, 26(3), 245-55.
  6. Malliaras KG, Terrovitis JV, Drakos SG, Nanas JN (2009). Reverse cardiac remodeling enabled by mechanical unloading of the left ventricle. [Review]. J Cardiovasc Transl Res, 2(1), 114-25.
  7. Terrovitis JV, Anastasiou-Nana M, Kaldara E, Drakos SG, Nanas SN, Nanas JN (2009). Anemia in heart failure: pathophysiologic insights and treatment options. [Review]. Future Cardiol, 5(1), 71-81.
  8. Drakos SG, Anastasiou-Nana MI, Malliaras KG, Nanas JN (2009). Anemia in chronic heart failure. [Review]. Congest Heart Fail, 15(2), 87-92.
  9. Drakos SG, Charitos EI, Nanas SN, Nanas JN (2007). Ventricular-assist devices for the treatment of chronic heart failure. [Review]. Expert Rev Cardiovasc Ther, 5(3), 571-84.
  10. Drakos SG, Terrovitis JV, Anastasiou-Nana MI, Nanas JN (2007). Reverse remodeling during long-term mechanical unloading of the left ventricle. [Review]. J Mol Cell Cardiol, 43(3), 231-42.

Book Chapter

  1. Diakos NA, Wever-Pinzon O, Zannas AS, Drakos SG (2013). Mechanical unloading and heart remodeling features. In Edmo Gabriel, Sthefano Gabriel (Eds.), Inflammatory response in cardiovascular surgery, New York, NY: Springer.
  2. Terrovitis JV, Tseliou E, Drakos SG, Nanas JN (2011). Evaluation of Cardiac Function after VAD Implantation, New Aspects of Ventricular Assist Devices, Guillermo Reyes (Ed.), ISBN: 978-953-307-676-8, InTech, Available from :
  3. Tsagalou EP, Drakos SG, Tsolakis E, Nanas J (2008). Intra-aortic balloon pump in the management of acute heart failure syndromes. In Alexandre Mebazaa, Mihai Gheorghiade, Faiez Zannad, Joseph Parrillo (Eds.), Acute Heart Failure (pp. 671-684). New York, NY: Springer.
  4. Drakos SG, Alexopoulos G, Nanas JN (2005). Organizing a heart failure program. In Filippatos G, Adamopoulos S, Parissis J, Anthopoulos L, Kremastinos D (Eds.), Heart Failure: from diagnosis to treatment (pp. 453-464). Athens, Greece: Paschalides Editions.

Conference Proceedings

  1. Drakos SG, Bonios M, Terrovitis JV, Panagiotopoulos G, Pozios I, Diakos N, Tseliou E, Malliaras K, Kanakakis J, Anastasiou-Nana MI (2009). Commonly used risk factors failed to accurately predict survival in patients with advanced heart failure. (Indexed in Current Contents of ISI, Philadelphia, USA). Proceedings of the 14th World Congress on Heart Disease, 251.
  2. Bonios M, Drakos SG, Anastasiou-Nana M, Tsagalou E, Ntalianis A, Maroulidis G, Venetsanakos J, Lazaris N, Kanakakis J, Nanas J (2007). Prognosis of Post-Myocardial Infarction Cardiogenic Shock Patients that Require Mechanical Ventilation. (indexed in Current Contents of ISI, Philadelphia, USA). Proceedings of the 13th World Congress on Heart Dis, XV, 383-7.


  1. Uriel N, Drakos SG (2015). Spotlight on new therapies in heart failure. Curr Opin Cardiol (30(3), pp. 246-9). United States.
  2. Drakos SG, Uriel N (2014). Spotlight on cardiogenic shock therapies in the era of mechanical circulatory support. Curr Opin Cardiol (29(3), pp. 241-3). United States.

Global Impact

Global Impact

Education History

Type School Degree Country
Fellowship University of Athens
General Cardiology Fellowship
Fellow Greece
Doctoral Training University of Athens
Pulsatile vs. Non Pulsatile Mechanical Support in a Porcine Model of Heart Failure, Summa Cum Laude
Ph.D. Greece
Residency University of Athens
Internal Medicine
Resident Greece
Professional Medical University of Athens
Medicine, Summa Cum Laude
M.D. Greece


Institution Description Country
University of Athens Faculty Cardiologist Greece

Clinical Trials

Clinical Trials

Video & News